(5Z,13E)- (15S)- 11α,15- dihydroxy- 9- oxoprost- 13- enoate:NAD+ 15- oxidoreductase inhibitor
|
ChEBI
|
(5Z,13E)- (15S)- 11α,15- dihydroxy- 9- oxoprost- 13- enoate:NAD+ 15- oxidoreductase inhibitors
|
ChEBI
|
(5Z,13E,15S)- 11α,15- dihydroxy- 9- oxoprost- 5,13- dienoate:NAD+ 15- oxidoreductase inhibitor
|
ChEBI
|
(5Z,13E,15S)- 11α,15- dihydroxy- 9- oxoprost- 5,13- dienoate:NAD+ 15- oxidoreductase inhibitors
|
ChEBI
|
11α,15- dihydroxy- 9- oxoprost- 13- enoate:NAD+ 15- oxidoreductase inhibitor
|
ChEBI
|
11α,15- dihydroxy- 9- oxoprost- 13- enoate:NAD+ 15- oxidoreductase inhibitors
|
ChEBI
|
15-hydroxyprostaglandin dehydrogenase (NAD+) (EC 1.1.1.141) inhibitor
|
ChEBI
|
15-hydroxyprostaglandin dehydrogenase (NAD+) (EC 1.1.1.141) inhibitors
|
ChEBI
|
15-hydroxyprostaglandin dehydrogenase (NAD+) inhibitor
|
ChEBI
|
15-hydroxyprostaglandin dehydrogenase (NAD+) inhibitors
|
ChEBI
|
15-hydroxyprostaglandin dehydrogenase inhibitor
|
ChEBI
|
15-hydroxyprostaglandin dehydrogenase inhibitors
|
ChEBI
|
15-hydroxyprostanoic dehydrogenase inhibitor
|
ChEBI
|
15-hydroxyprostanoic dehydrogenase inhibitors
|
ChEBI
|
15-OH-PGDH inhibitor
|
ChEBI
|
15-OH-PGDH inhibitors
|
ChEBI
|
EC 1.1.1.141 [15-hydroxyprostaglandin dehydrogenase (NAD+)] inhibitors
|
ChEBI
|
EC 1.1.1.141 inhibitor
|
ChEBI
|
EC 1.1.1.141 inhibitors
|
ChEBI
|
NAD+-dependent 15-hydroxyprostaglandin dehydrogenase (type I) inhibitor
|
ChEBI
|
NAD+-dependent 15-hydroxyprostaglandin dehydrogenase (type I) inhibitors
|
ChEBI
|
NAD-specific 15-hydroxyprostaglandin dehydrogenase inhibitor
|
ChEBI
|
NAD-specific 15-hydroxyprostaglandin dehydrogenase inhibitors
|
ChEBI
|
PGDH inhibitor
|
ChEBI
|
PGDH inhibitors
|
ChEBI
|
prostaglandin dehydrogenase inhibitor
|
ChEBI
|
prostaglandin dehydrogenase inhibitors
|
ChEBI
|